Outlook Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Outlook Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q4 2024.
  • Outlook Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $263K, a 1657% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $263K +$248K +1657% Dec 31, 2024 10-Q 2025-02-14
Q3 2024 $275K +$248K +949% Sep 30, 2024 10-Q 2025-02-14
Q2 2024 $286K +$249K +666% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.74K -$44.8K -92.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $15K -$44.6K -74.9% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $26.2K -$44.2K -62.8% Sep 30, 2023 10-K 2024-12-27
Q2 2023 $37.4K -$43.5K -53.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $48.6K -$42.7K -46.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $59.6K -$41.9K -41.3% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $70.4K -$41.1K -36.9% Sep 30, 2022 10-K 2023-12-22
Q2 2022 $80.9K -$40.3K -33.2% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $91.3K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $101K -$25.3K -20% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $111K -$55.6K -33.3% Sep 30, 2021 10-K 2022-12-29
Q2 2021 $121K -$85K -41.2% Jun 30, 2021 10-Q 2021-08-13
Q4 2020 $127K -$155K -55.1% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $167K Sep 30, 2020 10-K 2021-12-23
Q2 2020 $206K Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $245K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $282K Dec 31, 2019 10-Q 2020-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.